Rongpu Liang
Overview
Explore the profile of Rongpu Liang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
223
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liang R, Liu L, Ding D, Li Y, Ren J, Wei B
Cancer Immunol Immunother
. 2025 Feb;
74(3):94.
PMID: 39891722
Background: CD155 is a crucial factor in the regulation of T cell function and contributes to immune escape. CD155 upregulation has been found in several types of cancer. However, the...
2.
Liang R, Ding D, Li Y, Lan T, Ryabtseva S, Huang S, et al.
J Nanobiotechnology
. 2024 Dec;
22(1):753.
PMID: 39676171
Background: Immunotherapy for colorectal cancer (CRC) with microsatellite stability (MSS) and mismatch repair proficiency (pMMR) has shown limited success in clinical trials. The combination of immunomodulators and immune checkpoint inhibitors...
3.
Ding D, Liang R, Li T, Lan T, Li Y, Huang S, et al.
J Control Release
. 2024 Mar;
369:309-324.
PMID: 38554771
Immunotherapy based on the PD-1/PD-L1 axis blockade has no benefit for patients diagnosed with colon cancer liver metastasis (CCLM) for the microsatellite stable/proficient mismatch repair (MSS/pMMR)) subtype, which is known...
4.
Huang S, Ding D, Lan T, He G, Ren J, Liang R, et al.
Acta Biomater
. 2023 Apr;
164:538-552.
PMID: 37037269
Liver metastasis is the leading cause of death in colorectal cancer. Immunotherapy using immune checkpoint blockade (ICB) is ineffective due to its immunological cold tumor nature. Herein, we prepared a...
5.
Shao J, Nie P, Yang W, Guo R, Ding D, Liang R, et al.
Bioeng Transl Med
. 2022 Sep;
7(3):e10319.
PMID: 36176612
Neurogenic erectile dysfunction (nED) is one of the most common and intractable postoperative complications of rectal and prostate cancer surgery and sometimes accompanies patients lifelong. The transplantation of stem cells...
6.
Zhu X, Liang R, Lan T, Ding D, Huang S, Shao J, et al.
J Immunother Cancer
. 2022 Sep;
10(9).
PMID: 36104099
Background: Onco-immunogenic molecule CD155 is overexpressed in various tumor microenvironments (TME) including in colorectal cancer (CRC). Tumor-associated macrophages (TAMs) are the most abundant immune cells in CRC TME and play...
7.
Li W, Zheng R, Yang X, Liang R, Wei B, Jiang T, et al.
Clin Lab
. 2021 Sep;
67(9).
PMID: 34542979
Background: Chest CT is important for the diagnosis of Corona Virus Disease 2019, which is caused by SARS-CoV-2 via the receptor angiotensin-converting enzyme 2. This study aimed to present special...
8.
Li W, Zheng R, Liang R, Wu B, Wang C, Zhuo L, et al.
Clin Lab
. 2021 Jul;
67(7).
PMID: 34258966
Background: Respiratory epithelium expressing angiotensin-converting enzyme 2 (ACE2) is the entry for novel coronavirus (SARS-CoV-2), pathogen of the COVID-19 pneumonia outbreak, although a few recent studies have found different ACE2...
9.
Ding D, Zhong H, Liang R, Lan T, Zhu X, Huang S, et al.
Adv Sci (Weinh)
. 2021 May;
8(14):e2100712.
PMID: 34021727
An ideal tumor treatment is supposed to eliminate the primary tumor and simultaneously trigger the host antitumor immune responses to prevent tumor recurrence and metastasis. Herein, a liposome encapsulating phosphoinositide...
10.
Shao J, Liang R, Ding D, Zheng X, Zhu X, Hu S, et al.
Int J Nanomedicine
. 2021 Apr;
16:2897-2915.
PMID: 33907399
Background: Surgery is considered to be a potentially curative approach for gastric cancer. However, most cases are diagnosed at a very advanced stage for the lack of typical symptoms in...